Trial Profile
A retrospective study of dapagliflozin in patients with uncontrolled type 2 diabetes mellitus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Dec 2016
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 15 Dec 2016 New trial record
- 01 Dec 2016 Results published in the Diabetes Therapy.